PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer using its proprietary Cell-in-a-Box live cell encapsulation technology. Its lead product candidate, CypCaps, encapsulates genetically engineered human cells that convert a cancer prodrug into its active cancer-killing form, targeting locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC). The company submitted an IND to the FDA in 2020, which was placed on clinical hold pending resolution of nonclinical and manufacturing requirements.
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-29 | 2026-04-30 | 0001683168-26-005836 | EDGAR | — |
| 2025-08-11 | 2025-04-30 | 0001683168-25-005821 | EDGAR | 103K words |
| 2024-08-13 | 2024-04-30 | 0001683168-24-005575 | EDGAR | — |
| 2023-07-31 | 2023-04-30 | 0001683168-23-005175 | EDGAR | — |
| 2022-07-28 | 2022-04-30 | 0001683168-22-005189 | EDGAR | — |
| 2021-08-10 | 2021-04-30 | 0001683168-21-003377 | EDGAR | — |
| 2020-08-13 | 2020-04-30 | 0001683168-20-002680 | EDGAR | — |
| 2019-08-13 | 2019-04-30 | 0001683168-19-002559 | EDGAR | — |
| 2018-07-20 | 2018-04-30 | 0001683168-18-001994 | EDGAR | — |
| 2017-07-27 | 2017-04-30 | 0001683168-17-001881 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2026-01-31 | 0001683168-26-001917 | EDGAR | 30K words |
| 2025-12-18 | 2025-10-31 | 0001683168-25-009259 | EDGAR | — |
| 2025-09-15 | 2025-07-31 | 0001683168-25-006991 | EDGAR | — |
| 2025-03-17 | 2025-01-31 | 0001683168-25-001669 | EDGAR | — |
| 2024-12-13 | 2024-10-31 | 0001683168-24-008709 | EDGAR | — |
| 2024-09-17 | 2024-07-31 | 0001683168-24-006441 | EDGAR | — |
| 2024-03-18 | 2024-01-31 | 0001683168-24-001525 | EDGAR | — |
| 2023-12-15 | 2023-10-31 | 0001683168-23-008889 | EDGAR | — |
| 2023-09-18 | 2023-07-31 | 0001683168-23-006505 | EDGAR | — |
| 2023-03-16 | 2023-01-31 | 0001683168-23-001559 | EDGAR | — |
| 2022-12-14 | 2022-10-31 | 0001683168-22-008428 | EDGAR | — |
| 2022-09-14 | 2022-07-31 | 0001683168-22-006394 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001683168-26-002613 | EDGAR | 12K words |
| 2025-12-05 | 0001683168-25-008947 | EDGAR | — |
| 2025-10-31 | 0001683168-25-007871 | EDGAR | — |
| 2025-09-05 | 0001683168-25-006727 | EDGAR | — |
| 2025-08-18 | 0001683168-25-006274 | EDGAR | — |
| 2025-04-24 | 0001683168-25-002790 | EDGAR | — |
| 2025-02-26 | 0001683168-25-001236 | EDGAR | — |
| 2024-05-23 | 0001683168-24-003796 | EDGAR | — |
| 2024-05-01 | 0001683168-24-002881 | EDGAR | — |
| 2023-11-24 | 0001683168-23-008446 | EDGAR | — |
226 total filings indexed. 194 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001157075 |
| Ticker | PMCB |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Website | https://pharmacyte.com |
| Listed | 2003-09-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PMCB (~200 tokens, structured JSON with cryptographic provenance)